Fidelity Investments’s PhaseRx, Inc. PZRX Stock Holding History

Fidelity Investments’s Portfolio PZRX Stock Details PZRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-546,362	Closed	-$847K	–	2749
2016 Q4	$847K	Sell	546,362 -295,607	-35%	-$482K	﹤0.01%	2489
2016 Q3	$2.16M	Sell	841,969 -158,031	-16%	-$515K	﹤0.01%	2354
2016 Q2	$4.26M	Buy	+1,000,000	New	+$4.94M	﹤0.01%	2221

Other funds holding PZRX

Credit Agricole Montrouge Cedex, France $38.1B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RFC

Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments's PZRX Position: Q1 2017 in Review

Fidelity Investments sold out of PhaseRx, Inc. (PZRX) in Q1 2017, closing a stake of 546,362 shares — an estimated $847K sold.

Fidelity Investments first reported a position in PZRX in Q2 2016 and held it in 3 quarters. The position peaked at $4.26M in Q2 2016. 5 funds tracked by Wall St. Rank hold PZRX as of Q1 2017.

Fidelity Investments reported no remaining PhaseRx, Inc. position as of Q1 2017 after selling out during the quarter.
Fidelity Investments sold 546,362 PhaseRx, Inc. shares in Q1 2017, an estimated $847K.
Fidelity Investments first reported a position in PhaseRx, Inc. in Q2 2016 and held it in 3 quarters.
Fidelity Investments's PhaseRx, Inc. position peaked at $4.26M in Q2 2016.
5 funds tracked by Wall St. Rank held PhaseRx, Inc. as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.